FLUOCINONIDE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 450 adverse event reports in the FDA FAERS database where FLUOCINONIDE was used for Psoriasis.
Most Reported Side Effects for FLUOCINONIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 458 | 43.6% | 0 | 2 |
| Psoriasis | 238 | 22.7% | 0 | 1 |
| Pruritus | 119 | 11.3% | 0 | 2 |
| Product use in unapproved indication | 102 | 9.7% | 0 | 2 |
| Treatment failure | 97 | 9.2% | 0 | 0 |
| Therapeutic product effect incomplete | 96 | 9.1% | 0 | 0 |
| Skin exfoliation | 71 | 6.8% | 0 | 1 |
| Rash | 65 | 6.2% | 0 | 3 |
| Erythema | 64 | 6.1% | 0 | 4 |
| Off label use | 47 | 4.5% | 0 | 1 |
| Arthralgia | 43 | 4.1% | 0 | 1 |
| Psoriatic arthropathy | 35 | 3.3% | 0 | 1 |
| Skin plaque | 34 | 3.2% | 0 | 0 |
| Pain | 31 | 3.0% | 0 | 3 |
| Papule | 28 | 2.7% | 0 | 1 |
Other Indications for FLUOCINONIDE
Product used for unknown indication (152)
Pruritus (37)
Eczema (36)
Rash (34)
Psoriatic arthropathy (29)
Dermatitis atopic (26)
Seborrhoeic dermatitis (12)
Dermatitis (11)
Dry skin (9)
Hidradenitis (9)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)